Unichem Laboratories Receives CGST Order-In-Appeal with Rs 87.07 Crore Penalty

Unichem Laboratories Receives CGST Order-In-Appeal with Rs 87.07 Crore Penalty
Published on September 19, 2026|Author: Team Choice

Unichem Laboratories Regulatory Order Details

The Order-In-Appeal was issued by the Commissioner (Appeals), Thane and relates to proceedings concerning the cross-charge of common services.

The matter involves tax, interest and penalty proceedings under the Central Goods and Services Tax (CGST) Act, 2017 and related rules.

According to the disclosure, the matter involves delayed payment of tax liability and alleged contravention of Section 13 of the CGST Act, 2017 and Rule 47 of the CGST Rules, 2017.

Unichem Laboratories CGST Penalty and Interest

The Order-In-Appeal includes a penalty of Rs 87,07,09,556, or approximately Rs 87.07 crore, under Sections 74(1) and 122(2)(b) of the CGST Act, 2017.

The order also includes an interest liability of Rs 6,58,590, equivalent to approximately Rs 6.58 lakh, in connection with the delayed payment of tax liability.

Unichem Laboratories Response to CGST Order

Unichem Laboratories stated that there would be no material impact on the financial, operational or other activities of the company from the order.

The company also stated that it will take appropriate remedial steps, including filing a further appeal within the prescribed timelines, based on legal advice.

Unichem Laboratories CGST Order Highlights

Company Unichem Laboratories Limited
Authority Commissioner (Appeals), Thane
Order Order-In-Appeal
Date of Receipt September 18, 2026, after 2:00 p.m.
Matter Cross-charge of common services
Penalty Rs 87,07,09,556 (approximately Rs 87.07 crore)
Interest Liability Rs 6,58,590 (approximately Rs 6.58 lakh)
Relevant Provisions Sections 74(1) and 122(2)(b) of the CGST Act, 2017
Other Provisions Cited Section 13 of the CGST Act, 2017 and Rule 47 of the CGST Rules, 2017
Company's Position No material impact on financial, operational or other activities
Next Step Further appeal within the prescribed timelines, based on legal advice

What to Watch Next

  • Investors may track Unichem Laboratories' further disclosures regarding the proposed appeal.
  • The outcome of any further appellate proceedings may provide additional clarity on the tax, penalty and interest liabilities.
  • Investors can also monitor subsequent regulatory filings for updates on the matter.

Disclaimer

Investments in the securities market are subject to market risks. Read all related documents carefully before investing. Registration granted by SEBI, and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of returns to investors. Choice Equity Broking Private Limited: SEBI Reg No. Broking - INZ000160131 ( BSE - 3299 ) | ( NSE - 13773 ) | ( MSEI - 73200 ) | ( MCX - 40585 ) | ( NCDEX - 01006 ). Depository Participant SEBI Reg. No. - IN - DP - 84 - 2015, DP ID CDSL - 12066900, NSDL ID - IN301895. Research Analyst - INH000000222 (CIN. NO.: U65999MH2010PTC198714)

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations